Although an increased Gal-3 concentration was found to be an independent predictor of mortality and HF hospitalization in chronic HF, the role of Gal-3 in remodelling has not been conclusively demonstrated in patients with heart failure with reduced ejection fraction (HFrEF)4,7,8. This evidence concerns the gene LGALS3 and heart failure.